Comparative study of thulium and holmium laser in non-muscle invasive bladder cancer
- Авторлар: Popov S.V.1,2, Guseinov R.G.1,3, Pomeshkin E.V.1, Skryabin O.N.1, Sivak K.V.1,4, Perepelitsa V.V.1, Lelyavina T.A.1,5, Malyshev E.A.1
-
Мекемелер:
- Saint Luka City Hospital
- S.M. Kirov Military Medical Academy of the Ministry of Defense of Russian Federation
- Saint Petersburg State University
- A.A. Smorodintsev Research Institute of Influenza of the Ministry of Health of Russia
- National Medical Research Center named after V.A. Almazov of the Ministry of Health of the Russian Federation
- Шығарылым: № 4 (2024)
- Беттер: 81-86
- Бөлім: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/1728-2985/article/view/264903
- DOI: https://doi.org/10.18565/urology.2024.4.81-86
- ID: 264903
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
Aim. To compare thulium and holmium lasers in the treatment of non-muscle invasive bladder cancer (NMIBC).
Materials and methods. In our work, patients were divided into 3 groups, depending on the treatment method. In the group 1 (n=27, 32.14% of the cohort), thulium laser resection of the bladder was done, while in the group 2 (n=25, 29.76% of the cohort) and group 3 (n=32, 38.10 % of the cohort) holmium laser resection and standard transurethral resection (TUR) were performed, respectively. In the preoperative period, all patients underwent a standard clinical examinations and imaging studies (computed tomography of the thorax, abdomen and retroperitoneal space, magnetic resonance imaging of the pelvis, cystoscopy, cytological examination of urine sediment).
Results. The duration of the procedure was 14.7±5.2 minutes for a thulium laser and 16.3±5.3 minutes for a holmium laser, compared to 20.5±7.4 minutes for standard TUR. The duration of postoperative irrigation after laser resection was lower (4.4±1.8, 4.7±1.6 and 16.4±2.5 hours, respectively) (p<0.001). The period of postoperative catheterization in groups 1 and 2 was 1.5±0.08 and 1.6±0.08 days, respectively, compared to 2.5± 0.13 days in the group 3 (p=0.002). In the group of thulium and holmium laser resection, a higher disease-free survival was demonstrated compared with TUR throughout the entire follow-up period.
Conclusion. When performing laser resection of the bladder wall for NMIBC, a significant lower number of complications and better survival were documented compared to patients who underwent TUR.
Толық мәтін
##article.viewOnOriginalSite##Авторлар туралы
S. Popov
Saint Luka City Hospital; S.M. Kirov Military Medical Academy of the Ministry of Defense of Russian Federation
Хат алмасуға жауапты Автор.
Email: doc.popov@gmail.com
ORCID iD: 0000-0003-2767-7153
PhD, MD, Professor, Chief; Head of the Center of Endourology and New Technologies, Professor at the Department of Urology
Ресей, Saint Petersburg; Saint PetersburgR. Guseinov
Saint Luka City Hospital; Saint Petersburg State University
Email: rusfa@yandex.ru
ORCID iD: 0000-0001-9935-0243
PhD, Deputy Director on Scientific Work; Assistant at the Department of Hospital Surgery
Ресей, Saint Petersburg; Saint PetersburgE. Pomeshkin
Saint Luka City Hospital
Email: pomeshkin@mail.ru
PhD, Head of the Department of Urology
Ресей, Saint PetersburgO. Skryabin
Saint Luka City Hospital
Email: skryabin_55@mail.com
ORCID iD: 0000-0002-6664-2861
PhD, MD, Professor, Chief Oncologist, Scientific Chief of the Center of Endourology and New Technologies
Ресей, Saint PetersburgK. Sivak
Saint Luka City Hospital; A.A. Smorodintsev Research Institute of Influenza of the Ministry of Health of Russia
Email: kvsivak@gmail.com
ORCID iD: 0000-0003-4064-5033
PhD, MD, Leading Researcher
Ресей, Saint Petersburg; Saint PetersburgV. Perepelitsa
Saint Luka City Hospital
Email: perepelitsa_vit@mail.ru
ORCID iD: 0000-0002-7656-4473
PhD, Urologist
Ресей, Saint PetersburgT. Lelyavina
Saint Luka City Hospital; National Medical Research Center named after V.A. Almazov of the Ministry of Health of the Russian Federation
Email: tatianalelyavina@mail.com
ORCID iD: 0000-0001-6796-4064
Researcher; PhD, MD, Leading Researcher
Ресей, Saint Petersburg; Saint PetersburgE. Malyshev
Saint Luka City Hospital
Email: info@lucaclinic.ru
Researcher
Ресей, Saint PetersburgӘдебиет тізімі
- Gusniev M. A., Pechnikova V. V., Gushchin M. Yu., Gusniev S. A., Gioeva Z. V., Pshikhachev A.M., Mikhaleva L.M. Analysis of risk factors for recurrence of non-musculoskeletal invasive bladder cancer after its combined treatment. Medical Bulletin of the North Caucasus. 2022;17(3):264–268. Day https://doi.org/10.14300/mnnc.2022.17064. Russian (Гусниев М. А., Печникова В.В., Гущин М.Ю., Гусниев С.А., Гиоева З.В., Пшихачев А.М., Михалева Л.М. Анализ факторов риска рецидива немышечно-инвазивного рака мочевого пузыря после его комбинированного лечения. Медицинский вестник Северного Кавказа. 2022;17(3):264–268. Doi https://doi.org/10.14300/mnnc. 2022.17064).
- Shore N.D., Palou Redorta J., Robert G., Hutson T.E., Cesari R., Hariharan S., Rodríguez Faba Ó., Briganti A., Steinberg G.D. Non-muscle-invasive bladder cancer: An overview of potential new treatment options. Urol Oncol. 2021;39(10):642–663. doi: 10.1016/j.urolonc.2021.05.015.
- Al Hussein Al Awamlh, Chang, S.S. Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer. Curr Oncol Rep. 2023;25:83–91. doi: 10.1007/s11912-022-01350-9.
- Ivakhno K.Yu., Vazhenin A.V., Karnaukh P.A., Misyukevich N.D. World experience in the use of a thule laser in the treatment of noninvasive muscle bladder cancer // Bulletin of the Council of Young Scientists of the Chelyabinsk region. 2018. № 1(20). URL: https://cyberleninka.ru/article/n/mirovoy-opyt-primenenie-tulievogo-lazera-v-lechenii-myshechno-neinvazivnogo-raka-mochevogo-puzyrya (date of application: 05/15/2023). Russian (Ивахно К.Ю., Важенин А.В., Карнаух П.А., Мисюкевич Н.Д. Мировой опыт применение тулиевого лазера в лечении мышечно-неинвазивного рака мочевого пузыря // Вестник Совета молодых ученых Челябинской области. 2018. № 1(20). URL: https://cyberleninka.ru/article/n/mirovoy-opyt-primenenie-tulievogo-lazera-v-lechenii-myshechno-neinvazivnogo-raka-mochevogo-puzyrya (дата обращения: 15.05.2023).
- Li C., Gao L., Zhang J., Yang X., Liu C. The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Lasers Med Sci. 2020;35:1025–1034. 10.1007/s10103-020-02972-w
- Chen J., Zhao Y., Wang S., Jin X., Sun P., Zhang L., et al. Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor vs. transurethral electroresection: a prospective, nonrandomized two-center trial with 36-month follow-up. Lasers Surg Med (2016;48:859–865. doi: 10.1002/lsm.22565
- Xu Y., Guan W., Chen W., Xie C., Ouyang Y., Wu Y., et al. Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: a prospective, randomized study. Lasers Surg Med. 2015;47:306–11. doi: 10.1002/lsm.22342
- Jin Y.H., Zeng X.T., Liu T.Z., Bai Z.M., Dou Z.L., Ding D.G., Fan Z.L., Han P., Huang Y.R., Huang X., Li M., Li X.D., Li Y.N., Li X.H., Liang C.Z., Liu J.M., Ma H.S., Qi J., Shi J.Q., Wang J., Wang D.L., Wang Z.P., Wang Y.Y., Wang Y.B,. Wei Q., Xia H.B., Xing J.C., Yan S.Y., Zhang X.P., Zheng G.Y., Xing N.Z., He D.L., Wang X.H.; Chinese Urological Doctor Association (CUDA), Urological Association of Chinese Research Hospital Association (CRHA-UA), Uro-Health Promotive Association of China International Exchange, Promotive Association for Medical, Health Care (CPAM-UHPA). Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. 2022;9(1):44. doi: 10.1186/s40779-022-00406-y.
- Musat M.G., Kwon C.S., Masters E., Sikirica S., Pijush D.B., Forsythe A. Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR). Clinicoecon Outcomes Res. 2022;14:35–48. https://doi.org/10.2147/CEOR.S341896
- Liem E. et al. Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading. Eur Urol Focus. 2020;6:81. https://pubmed.ncbi.nlm.nih.gov/30033066.
- Poletajew S., Krajewski W., Gajewska D., Sondka-Migdalska J., Borowik M., Buraczyński P., Dzięgała M., Łykowski M., Przudzik M., Tukiendorf A., Woźniak R., Bar K., Jabłonowski Z., Roslan M., Słojewski M., Zdrojowy R., Radziszewski P., Dziobek K. Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour – a prospective multicentre observational study. Arch Med Sci. 20197;16(4):863–870. doi: 10.5114/aoms.2019.88430.
- Kamadjou C., Kuitche J., Wadeu A., Mbassi A., Angwafo F. Transurethral Resection of Bladder Tumours: Results and Outcomes. Open Journal of Urology. 2022;12:342–356. doi: 10.4236/oju.2022.126033.
- Lonati C., Esperto F., Scarpa R.M., Papalia R., Gómez Rivas J., Alvarez-Maestro M., Afferi L., Fankhauser C.D., Mattei A., Colombo R., Montorsi F., Briganti A., Krajewski W., Carando R., Laukhtina E., Teo J.Y., Zamboni S., Simeone C., Moschini M. European Association of Urology–Young Academic Urologists (EAU–YA U): Urothelial Carcinoma Working Group; European Association of Urology - European Society of Resident Urologists (EAU–ESRU). Bladder perforation during transurethral resection of the bladder: a comprehensive algorithm for diagnosis, management and follow-up. Minerva Urol Nephrol. 2022;74(5):570–580. doi: 10.23736/S2724-6051.21.04436-0.
- Kramer M.W. et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 2015;33:1937. doi: 10.1007/s00345-015-1568-6.
- Hurle R. et al. “En Bloc” Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study. Urology 2016;90:126. doi: 10.1016/j.urology.2016.01.004.
- Migliari R. et al. Thulium Laser Endoscopic En Bloc Enucleation of Non-muscleInvasive Bladder Cancer. J Endourol 2015;29:1258. doi: 10.1089/end.2015.0336.
- Zhang X.R. et al. Two Micrometer Continuous-Wave Thulium Laser Treating Primary Non-Muscle-Invasive Bladder Cancer: Is It Feasible? A Randomized Prospective Study. Photomed Laser Surg 2015;33:517. doi: 10.1089/pho.2015.3913.
- Long G., Zhang Y., Sun G., Ouyang W., Liu Z., Li H. Safety and efficacy of thulium laser resection of bladder tumors versus transurethral resection of bladder tumors: a systematic review and meta-analysis. Lasers Med Sci. 2021;18:1–10. 10.1007/s10103-021-03272-7.
Қосымша файлдар
